At TrimRx in Aurora, we specialize in the leading FDA-approved GLP-1 medications, primarily Semaglutide and Tirzepatide
Wegovy : This is another semaglutide medication, so its side effect profile is likely to be similar and depends on the dosage
Its official authorised indication is the treatment of type 2 diabetes mellitus in adults, in combination with diet and exercise, when glycaemic control is not achieved with other treatments
Patients should report if these symptoms worsen during rest or inactivity, improve with movement, and follow a pattern of being worse in the evening or nighttime hours
Mechanism of Action: Nauck & D'Alessio (2022) - "Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regarding glycaemic control and body weight reduction." Molecular Metabolism